Education
About Us
Working with TipRanks
Follow Us
SMAP - ETF AI Analysis
Top Page
Amplify Small-Mid Cap Equity ETF (SMAP)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Solid Top Holdings
Several of the largest positions, such as Monolithic Power, Curtiss-Wright, MKS, Eagle Materials, Watsco, and Casey’s General, have delivered strong year-to-date performance that supports the fund’s returns.
Diversified Sector Mix
Holdings spread across industrials, technology, financials, health care, and several other sectors help reduce the impact of weakness in any single industry.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which means more of the returns are eaten up by fees over time.
Small Asset Base
The ETF manages a relatively small amount of assets, which can sometimes lead to lower trading liquidity and wider bid-ask spreads for investors.
Heavy U.S. Concentration
With almost all of its holdings in U.S. companies, the fund offers very limited geographic diversification and is highly tied to the U.S. market.
SMAP vs. SPDR S&P 500 ETF (SPY)
AUM653.75K
RegionNorth America
Expense Ratio0.60%
Beta0.91
IssuerAmplify
Inception DateOct 23, 2024
Dividend Yield0.46%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume551
30 Day Avg. Volume310
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
29.65Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering59
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SMAP Summary
The Amplify Small-Mid Cap Equity ETF (SMAP) invests in smaller and mid-sized U.S. companies across many sectors, including industrials, technology, financials, and health care. It does not track a specific index, but instead focuses on the “extended market” beyond the biggest, well-known large-cap stocks. Top holdings include companies like Monolithic Power and Stifel Financial. An investor might choose SMAP to seek higher growth potential and add diversification beyond large companies. A key risk is that smaller and mid-sized stocks can be more volatile and can go up and down more sharply than the overall market.
How much will it cost me?The Amplify Small-Mid Cap Equity ETF (SMAP) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, which typically involves more research and trading compared to passively managed funds. Active management aims to outperform the market by selecting specific investments, which can justify the higher cost.
What would affect this ETF?The Amplify Small-Mid Cap Equity ETF (SMAP) could benefit from economic growth and innovation in sectors like technology and industrials, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates or economic slowdowns, which can disproportionately impact smaller companies. Additionally, its U.S.-focused exposure means it is sensitive to domestic economic and regulatory changes.
SMAP Top 10 Holdings
SMAP’s story is driven by a handful of standout U.S. small and mid-caps, with industrials, tech, and financials clearly in the driver’s seat. Curtiss-Wright and MKS Instruments are powering ahead, giving the fund a nice boost from industrial and semiconductor-related strength, while Monolithic Power adds steady tech momentum. On the flip side, West Pharmaceutical Services is losing steam and acting as a bit of a brake, and Markel has been mixed. With no single mega-cap dominating, the fund leans into diversified, domestically focused growth rather than one big thematic bet.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Monolithic Power | 3.97% | $25.85K | $56.93B | 82.14% | 75 Outperform | |
| MKS | 3.10% | $20.18K | $16.82B | 141.61% | 75 Outperform | |
| Stifel Financial | 3.08% | $20.06K | $12.27B | 14.93% | 75 Outperform | |
| Casey's General | 2.85% | $18.57K | $24.38B | 63.49% | 68 Neutral | |
| Watsco | 2.83% | $18.43K | $17.02B | -17.87% | 71 Outperform | |
| West Pharmaceutical Services | 2.81% | $18.29K | $17.88B | 15.61% | 68 Neutral | |
| Eagle Materials | 2.81% | $18.28K | $7.28B | 4.56% | 77 Outperform | |
| Curtiss-Wright | 2.81% | $18.27K | $25.47B | 122.18% | 74 Outperform | |
| Webster Financial | 2.66% | $17.33K | $11.68B | 29.39% | 77 Outperform | |
| Markel | 2.54% | $16.54K | $26.12B | 12.49% | 82 Outperform |
SMAP Technical Analysis
Positive
―
Price Trends
25.62
Positive
25.20
Positive
24.76
Positive
Market Momentum
0.16
Positive
56.49
Neutral
57.14
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMAP, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 25.96, equal to the 50-day MA of 25.62, and equal to the 200-day MA of 24.76, indicating a bullish trend. The MACD of 0.16 indicates Positive momentum. The RSI at 56.49 is Neutral, neither overbought nor oversold. The STOCH value of 57.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMAP.
SMAP Peer Comparison
Comparison Results
Performance Comparison
SMAP
Amplify Small-Mid Cap Equity ETF
26.22
2.38
9.98%
OASC
OneAscent Small Cap Core ETF
―
―
―
SMOX
Horizon Small/Mid Cap Core Equity ETF
―
―
―
ASCE
Allspring SMID Core ETF
―
―
―
HSMV
First Trust Horizon Managed Volatility Small/Mid ETF
―
―
―
MYLD
Cambria Micro and SmallCap Shareholder Yield ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents